Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AAK1 | Q2M2I8 | 1/20 | 0.32 |
| ▸ | ANO1 | Q5XXA6 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3620703 | 0.88 | AAK1 (0.34) | AAK1SMN1; SMN2 | |
| SCHEMBL3619979 | 0.86 | HSD17B10 (0.35) | ANO1SMN1; SMN2 | |
| SCHEMBL3613987 | 0.85 | SMN1; SMN2 (0.36) | AAK1SMN1; SMN2 | |
| SCHEMBL535142 | 0.80 | AAK1 (0.31) | AAK1SMN1; SMN2 | |
| SCHEMBL535141 | 0.80 | AAK1 (0.31) | AAK1SMN1; SMN2 | |
| SCHEMBL13077738 | 0.78 | ANO1 (0.31) | ANO1 | |
| SCHEMBL14762938 | 0.78 | ANO1 (0.31) | ANO1 | |
| SCHEMBL13077956 | 0.77 | EGLN1 (0.32) | SMN1; SMN2 | |
| SCHEMBL3617277 | 0.77 | SMN1; SMN2 (0.52) | SMN1; SMN2 | |
| SCHEMBL14763113 | 0.76 | ALDH1A1 (0.42) | ANO1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100113513-A1 | QUINOLINE DERIVATIVES AS FUNGICIDES | SYNGENTA CROP PROTECTION, INC. (US) | 2010-05-06 | — | — | US | disclosed |
| EP-2139324-A1 | QUINOLINE DERIVATIVES AS FUNGICIDES | Syngeta Participations AG (CH) | 2010-01-06 | — | — | EP | disclosed |
| WO-2008110355-A1 | QUINOLINE DERIVATIVES AS FUNGICIDES | SYNGENTA PARTICIPATIONS AG (CH) | 2008-09-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100113513-A1 | QUINOLINE DERIVATIVES AS FUNGICIDES | CYP1A1, CYP4X1, CYP3A7 | AAK1 4095/4885ANO1 674/4885SMN1; SMN2 3466/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.